P-241 EH21A1〜A4, benzenoid ansamycins, a new class of anti-tumor agents with conformational significance for Hsp90 inhibitory activity
スポンサーリンク
概要
- 論文の詳細を見る
- 天然有機化合物討論会の論文
- 2006-07-23
著者
-
Rahayu Endang
ガジャマダ大農工
-
Ichimura Michio
Biofrontier Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Rahayu Endang
Faculty Of Agricultural Technology Gadjah Mada University
-
Soga Shiro
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Kanda Yutaka
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Kaneko Masami
Biofrontier Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Ikeda Shunichi
Biofrontier Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
SUZUKI Makoto
BioFrontier Laboratories, Kyowa Hakko Kogyo Co. Ltd.
-
Onodera Hideyuki
BioFrontier Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
Uochi Yumiko
BioFrontier Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
Nakashima Takayuki
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
Takahashi Yuichi
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
Yamashita Yoshinori
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
Uochi Yumiko
Biofrontier Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Onodera Hideyuki
Biofrontier Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Ogawa H
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Yamashita Yoshinori
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Nakashima Takayuki
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Suzuki Makoto
Biofrontier Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Takahashi Yuichi
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Ichimura Michio
BioFrontier Laboratories, Kyowa Hakko Kogyo Co. Ltd.
関連論文
- UCH9, a New Antitumor Antibiotic Produced by Streptomyces: I. Producing Organism, Fermentation, Isolation and Biological Activities
- UCE6, a New Antitumor Antibiotic with Topoisomerase I-mediated DNA Cleavage Activty Produced by Actinomycetes: Producing Organism, Fermentation, Isolation and Biological Activity
- 46(P-7) 新規M期作用薬MPC1001および同族体の構造(ポスター発表の部)
- Pyrronamycin A and B, Novel Antitumor Antibiotics Containing Pyrrole-amide Repeating Unit, Produced by Streptomyces sp.
- UCT1072s, New Antitumor Antibiotics with Topoisomerase II Mediated DNA Cleavage Activity, from Aspergillus sp.
- A Radicicol Derivative, KF58333, Inhibits Expression of Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor, Angiogenesis and Growth of Human Breast Cancer Xenografts
- In Vitro and in Vivo Antitrypanosomal Activitiy of Two Microbial Metabolites, KS-505a and Alazopeptin
- YCM1008A, a Novel Ca^-Signaling Inhibitor, Produced by Fusarium sp. YCM1008
- P-241 EH21A1〜A4, benzenoid ansamycins, a new class of anti-tumor agents with conformational significance for Hsp90 inhibitory activity
- MPC1001, a New Antitumor Antibiotic Produced by Cladorrhinum sp
- Chrolactomycin, a Novel Antitumor Antibiotic Produced by Streptomyces sp.
- UCS1O25A, a Novel Antibiotic Produced by Acremonium sp.
- Belactosin A, a Novel Antitumor Antibiotic Acting on Cyclin/CDK Mediated Cell Cycle Regulation, Produced by Streptomyces sp.
- UCH9, a New Antitumor Antibiotic Produced by Streptomyces II. Structure Elucidation of UCH9 by Mass and NMR Spectroscopy
- 2Hp02 Lactic Acid Bacteria and Their Role in Food and Health : Research Activities